Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104
Single SC doses of RE104 resulted in a psychoactive experience and a favorable safety profile similar to psilocybin but with a shorter duration of psychoactive effect (3 to 4 hours). Results suggest a potential for therapeutic effect, warranting further study.
Authors
- Nathan Bryson (ORCID: https://orcid.org/0009-0002-4290-1264)
- Guy Ludbrook (ORCID: https://orcid.org/0000-0001-6925-4277)
- Matthew W. Johnson (ORCID: https://orcid.org/0000-0001-7068-0513)
- Glynn Morrish
- Brendan Taylor (ORCID: https://orcid.org/0000-0002-1567-525X)
- Jasna Hocevar‐Trnka
- Mark H. Pollack (ORCID: https://orcid.org/0000-0001-7240-2162)
- Joe Hirman
- Robert Alexander
Institutions
- Royal Adelaide Hospital (AU)
- Sheppard and Enoch Pratt Hospital (US)
- Morristown High School (US)
- Statistical Research (United States) (US)
- The University of Adelaide (AU)
Publication Details
- Journal
- Journal of Clinical Psychopharmacology
- Published
- 2025-07-21
- DOI
- https://doi.org/10.1097/jcp.0000000000002047
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00